Dr Reddy's Lab scales record high

Dr Reddy's Laboratories gained 2.74% to Rs 3,321 at 15:10 IST on BSE, with the stock extending intraday gain on defensive buying in weak market.

Meanwhile, the BSE Sensex was down 383.46 points, or 1.43%, to 26,361.23

On BSE, so far 33,051 shares were traded in the counter, compared with an average volume of 20,447 shares in the past one quarter.

The stock hit a record high of Rs 3,353.85 in intraday trade today, 25 September 2014. The stock hit an intraday low of Rs 3,233.50 so far during the day. The stock hit a 52-week low of Rs 2,250 on 19 May 2014.

The stock had outperformed the market over the past one month till 24 September 2014, rising 14.37% compared with 1.23% rise in the Sensex. The scrip, also outperformed the market in past one quarter, gaining 31.36% as against Sensex's 5.42% rise.

The large-cap company has an equity capital of Rs 85.18 crore. Face value per share is Rs 5.

On a consolidated basis, Dr Reddy's Laboratories' net profit surged 52.5% to Rs 550.39 crore on 23.6% growth in net sales to Rs 3517.54 crore in Q1 June 2014 over Q1 June 2013.

Dr Reddy's Laboratories is an integrated global pharmaceutical company. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - Dr Reddy's offers a portfolio of products and services including active pharmaceutical ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations.

Powered by Capital Market - Live News